Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Applebaum

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Oncotarget|October 22, 2016
Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patientsMark A Applebaum, Aashish R Jha, Clara Kao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Advances in Risk Classification and Treatment Strategies for NeuroblastomaNavin R Pinto, Mark A Applebaum, Samuel L Volchenboum, et al.
Pediatric Blood & Cancer|February 12, 2016
Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With RecurrenceNavin Pinto, Jodi R Mayfield, Gordana Raca, et al.
European Journal of Cancer (Oxford, England : 1990)|December 30, 2016
Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group ProjectMark A Applebaum, Zalman Vaksman, Sang Mee Lee, et al.
JCO Precision Oncology|June 11, 2019
5-Hydroxymethylcytosine Profiles Are Prognostic of Outcome in Neuroblastoma and Reveal Transcriptional Networks That Correlate With Tumor PhenotypeMark A Applebaum, Erin K Barr, Jason Karpus, et al.
Cancer|June 6, 2022
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual diseaseAmi V Desai, Mark A Applebaum, Theodore G Karrison, et al.
Cell Reports|May 1, 2024
Small-molecule inhibition of the METTL3/METTL14 complex suppresses neuroblastoma tumor growth and promotes differentiationMonica Pomaville, Mohansrinivas Chennakesavalu, Pingluan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2019
5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with NeuroblastomaMark A Applebaum, Erin K Barr, Jason Karpus, et al.
Communications Medicine|January 22, 2026
Introducing iCatalog as a clinical decision support tool for collaborative pediatric precision oncology studiesWenjun Kang, Lorena Lazo de la Vega, Hannah Comeau, et al.
NPJ Precision Oncology|November 7, 2024
Artificial intelligence-based morphologic classification and molecular characterization of neuroblastic tumors from digital histopathologySiddhi Ramesh, Emma Dyer, Monica Pomaville, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Oncotarget|October 22, 2016
Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patientsMark A Applebaum, Aashish R Jha, Clara Kao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Advances in Risk Classification and Treatment Strategies for NeuroblastomaNavin R Pinto, Mark A Applebaum, Samuel L Volchenboum, et al.
Pediatric Blood & Cancer|February 12, 2016
Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With RecurrenceNavin Pinto, Jodi R Mayfield, Gordana Raca, et al.
European Journal of Cancer (Oxford, England : 1990)|December 30, 2016
Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group ProjectMark A Applebaum, Zalman Vaksman, Sang Mee Lee, et al.
JCO Precision Oncology|June 11, 2019
5-Hydroxymethylcytosine Profiles Are Prognostic of Outcome in Neuroblastoma and Reveal Transcriptional Networks That Correlate With Tumor PhenotypeMark A Applebaum, Erin K Barr, Jason Karpus, et al.
Cancer|June 6, 2022
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual diseaseAmi V Desai, Mark A Applebaum, Theodore G Karrison, et al.
Cell Reports|May 1, 2024
Small-molecule inhibition of the METTL3/METTL14 complex suppresses neuroblastoma tumor growth and promotes differentiationMonica Pomaville, Mohansrinivas Chennakesavalu, Pingluan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2019
5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with NeuroblastomaMark A Applebaum, Erin K Barr, Jason Karpus, et al.
Communications Medicine|January 22, 2026
Introducing iCatalog as a clinical decision support tool for collaborative pediatric precision oncology studiesWenjun Kang, Lorena Lazo de la Vega, Hannah Comeau, et al.
NPJ Precision Oncology|November 7, 2024
Artificial intelligence-based morphologic classification and molecular characterization of neuroblastic tumors from digital histopathologySiddhi Ramesh, Emma Dyer, Monica Pomaville, et al.
Pageof 13